BMY
Bristol Myers Squibb
$63.75
−$0.66 (−1.02%)Sep 10, 2026
Key metrics
The numbers that frame BMY today
- Market cap
- $130.22B
- P/E (TTM)
- 14.0
- EV / FCF
- 14.4
- Gross margin
- 70.2%
- EV / Sales
- 3.3
- ROIC
- 19.3%
- Div yield
- 3.94%
- Debt / equity
- 1.9
- 52wk Low
- $41.14
- 52wk High
- $68.64
Growth
Revenue and earnings trend for BMY
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BMY
Is Bristol Myers Squibb a good buy?
Yes. Bristol Myers Squibb has excellent quality and excellent momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Bristol Myers Squibb is selling at a low price.
What is the market capitalization of BMY?
Bristol Myers Squibb's market capitalization is $130.22B.
What is the P/E ratio for BMY stock?
Bristol Myers Squibb's current P/E ratio is 14.
What is the 52-week high for BMY stock?
The 52-week high for Bristol Myers Squibb is $68.64. The current close of $63.75 is 7.1% below that high.
What is the 52-week low for BMY stock?
The 52-week low for Bristol Myers Squibb is $41.14. The current close of $63.75 is 55% above that low.
Does BMY stock pay dividends?
Bristol Myers Squibb pays a dividend. The latest dividend per share in the company data is $2.51, which implies a yield of 3.94% based on the current close.
What is the Debt / Equity ratio for BMY?
Bristol Myers Squibb's Debt / Equity ratio is 1.93.